Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (DE:82W)
FRANKFURT:82W
Hims & Hers Health (82W) Stock Forecast & Price Target
2 Followers
See the Price Targets and Ratings of:
82W Analyst Ratings
Moderate Buy
4 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
82W Stock 12 Month Forecast
Average Price Target
€19.04
▲(0.23% Upside)
| Highest Price Target€23.96 | Average Price Target€19.04 | Lowest Price Target€11.98 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
06/20/24
Leerink Partners
Reiterated
06/17/24
Seaport Global
Reiterated
05/30/24
Truist Financial
Assigned
05/23/24
Canaccord Genuity
Reiterated
05/21/24
Deutsche Numis
Reiterated
05/07/24
Piper Sandler
Reiterated
05/07/24
Robert W. Baird
Reiterated
05/06/24
Tigress Financial
€17.51
Buy
-7.87%
Downside
Reiterated
02/29/24
Hims & Hers Health: A Strong Buy on Accelerated Growth and Market Positioning
TD Cowen
€13.82
Buy
-27.26%
Downside
Reiterated
02/27/24
TD Cowen analyst Jonna Kim also increased her price target on the stock to $15 from $11, continuing to rate it at Outperform. Kim said in a research note that she likes the companys personalized offerings, which she said drive recurring revenues loyal engagement.
Guggenheim
€13.82→€15.66
Buy
-17.56%
Downside
Reiterated
02/27/24
We are incrementally more positive on HIMS after a solid 4Q print and even better outlook given by management, Guggenheim analyst Jack Wallace wrote in a research note after the earnings were disclosed on Monday.
Imperial Capital
€14.74
Buy
-22.41%
Downside
Upgraded
02/27/24
Hims & Hers upgraded to Outperform from In-Line at Imperial CapitalHims & Hers upgraded to Outperform from In-Line at Imperial Capital
Best Analysts Covering Hims & Hers Health
Which Analyst Should I Follow If I Want to Buy DE:82W and Sell After:
1 Month
3 Months
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+99.50%
reiterated a buy rating 4 months ago
Copying Jack Wallace's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +99.50% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
82W Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
1
1
1
3
3
Buy
9
6
8
8
11
Hold
8
8
7
9
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
15
16
20
24
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
82W Financial Forecast
82W Stock Forecast FAQ
What is DE:82W’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is €19.04.
What is DE:82W’s upside potential, based on the analysts’ average price target?
Hims & Hers Health has 0.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hims & Hers Health a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 6 hold ratings and 0 sell ratings.
What is Hims & Hers Health’s share price target?
The average share price target for Hims & Hers Health is €19.04. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €23.96 ,and the lowest forecast is €11.98. The average share price target represents 0.23% Increase from the current price of €19.
The highest analyst share price target is €23.96 ,and the lowest forecast is €11.98. The average share price target represents 0.23% Increase from the current price of €19.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of Hims & Hers Health?
To buy shares of DE:82W, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.